Evommune Inc
EVMN17.310USD
+0.650+3.90%
收盘 02/06, 16:00（美东）报价延迟15分钟
520.64M总市值
亏损市盈率 TTM
关于 公司
Evommune Inc简介
公司代码- -
公司名称- -
上市日期- -
CEO- -
员工数量- -
证券类型- -
年结日- -
公司地址- -
城市- -
上市交易所- -
国家- -
邮编- -
电话- -
网址- -
公司代码- -
上市日期- -
CEO- -
Evommune Inc公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Eugene A. Bauer, M.D.
Dr. Eugene A. Bauer, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
284.94K
-1478.00%
Ms. Janice Drew
Ms. Janice Drew
Executive Vice President - Operations
Executive Vice President - Operations
33.32K
-5074.00%
Mr. Luis Pena
Mr. Luis Pena
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Benjamin F. (Ben) McGraw, III
Dr. Benjamin F. (Ben) McGraw, III
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Kyle B. Carver, CPA
Mr. Kyle B. Carver, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Gregory S. Moss, Esq.
Mr. Gregory S. Moss, Esq.
Chief Business and Legal Officer, Corporate Secretary, Chief Compliance Officer
Chief Business and Legal Officer, Corporate Secretary, Chief Compliance Officer
--
--
Dr. Jeegar P. Patel, Ph.D.
Dr. Jeegar P. Patel, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Dr. Francois Beaubien, Ph.D.
Dr. Francois Beaubien, Ph.D.
Director
Director
--
--
Dr. David Eric Cohen, M.D.
Dr. David Eric Cohen, M.D.
Independent Director
Independent Director
--
--
Dr. Derek DiRocco, Ph.D.
Dr. Derek DiRocco, Ph.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Eugene A. Bauer, M.D.
Dr. Eugene A. Bauer, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
284.94K
-1478.00%
Ms. Janice Drew
Ms. Janice Drew
Executive Vice President - Operations
Executive Vice President - Operations
33.32K
-5074.00%
Mr. Luis Pena
Mr. Luis Pena
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Benjamin F. (Ben) McGraw, III
Dr. Benjamin F. (Ben) McGraw, III
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Kyle B. Carver, CPA
Mr. Kyle B. Carver, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Gregory S. Moss, Esq.
Mr. Gregory S. Moss, Esq.
Chief Business and Legal Officer, Corporate Secretary, Chief Compliance Officer
Chief Business and Legal Officer, Corporate Secretary, Chief Compliance Officer
--
--
收入明细
由于公司未披露，未能获取相关数据
由于公司未披露，未能获取相关数据
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 2月2日 周一
更新时间: 2月2日 周一
持股股东
股东类型
持股股东
持股股东
占比
EQT Life Sciences
15.64%
Pivotal Bioventure Partners Investment Advisor LLC
10.68%
RA Capital Management, LP
7.01%
Andera Partners S.A.S.
6.02%
SymBiosis II, L.L.C.
4.06%
其他
56.59%
持股股东
持股股东
占比
EQT Life Sciences
15.64%
Pivotal Bioventure Partners Investment Advisor LLC
10.68%
RA Capital Management, LP
7.01%
Andera Partners S.A.S.
6.02%
SymBiosis II, L.L.C.
4.06%
其他
56.59%
股东类型
持股股东
占比
Venture Capital
33.33%
Corporation
7.57%
Private Equity
6.02%
Investment Advisor
5.28%
Individual Investor
4.59%
Investment Advisor/Hedge Fund
1.95%
其他
41.27%
机构持股
更新时间: 1月21日 周三
更新时间: 1月21日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q4
4
12.40M
0.00%
--
2025Q4
14
14.63M
46.41%
+14.63M
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
EQT Life Sciences
4.93M
15.64%
+4.93M
--
Nov 07, 2025
Pivotal Bioventure Partners Investment Advisor LLC
3.37M
10.68%
+3.37M
--
Nov 06, 2025
RA Capital Management, LP
2.21M
7.01%
+2.21M
--
Nov 06, 2025
Andera Partners S.A.S.
1.90M
6.02%
+1.90M
--
Nov 07, 2025
SymBiosis II, L.L.C.
1.28M
4.06%
+1.28M
--
Nov 06, 2025
B Capital Group Management LP
1.10M
3.5%
+1.10M
--
Nov 06, 2025
Beaubien (Francois Ph.D.)
589.00K
1.87%
+589.00K
--
Nov 06, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
